| Breakdown | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 9.69B | 12.89B | 13.46B | 13.31B | 8.82B |
| Gross Profit | 2.70B | 3.70B | 3.32B | 2.78B | 2.04B |
| EBITDA | 780.02M | 1.84B | 1.67B | 1.29B | 668.05M |
| Net Income | 808.46M | 1.22B | 1.12B | 799.73M | 373.49M |
Balance Sheet | |||||
| Total Assets | 17.43B | 16.45B | 17.16B | 17.70B | 14.29B |
| Cash, Cash Equivalents and Short-Term Investments | 5.49B | 3.68B | 2.97B | 4.65B | 4.83B |
| Total Debt | 1.04B | 1.07B | 1.06B | 1.11B | 1.16B |
| Total Liabilities | 7.26B | 7.01B | 9.09B | 11.02B | 8.57B |
| Stockholders Equity | 10.16B | 9.44B | 8.07B | 6.68B | 5.72B |
Cash Flow | |||||
| Free Cash Flow | 2.08B | 962.54M | -1.40B | -164.21M | 3.00B |
| Operating Cash Flow | 2.28B | 1.01B | -1.37B | -91.12M | 3.03B |
| Investing Cash Flow | -35.17M | -109.92M | -86.55M | 71.26M | 26.77M |
| Financing Cash Flow | -438.56M | -186.23M | -236.15M | -157.94M | -125.72M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥5.61B | 6.64 | ― | 6.61% | -24.80% | -33.91% | |
72 Outperform | ¥54.19B | 28.20 | ― | 2.04% | 144.74% | 200.50% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥24.10B | 126.75 | ― | 2.77% | -11.58% | -82.90% | |
59 Neutral | ¥11.51B | 22.02 | ― | 2.71% | 1.90% | -54.49% | |
45 Neutral | ¥15.97B | 124.61 | ― | ― | -8.87% | ― |